Claudio Micheletto

2.4k total citations
104 papers, 1.3k citations indexed

About

Claudio Micheletto is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Claudio Micheletto has authored 104 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 64 papers in Physiology and 14 papers in Surgery. Recurrent topics in Claudio Micheletto's work include Asthma and respiratory diseases (58 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (33 papers) and Respiratory and Cough-Related Research (24 papers). Claudio Micheletto is often cited by papers focused on Asthma and respiratory diseases (58 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (33 papers) and Respiratory and Cough-Related Research (24 papers). Claudio Micheletto collaborates with scholars based in Italy, United Kingdom and Spain. Claudio Micheletto's co-authors include Silvia Tognella, Roberto W. Dal Negro, Massimo Guerriero, Carlo Pomari, Giorgio Walter Canonica, Gianenrico Senna, Laura De Ferrari, Marco Caminati, Alessandra Chiappori and A Riccio and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Emerging infectious diseases.

In The Last Decade

Claudio Micheletto

93 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Micheletto Italy 20 816 802 217 127 98 104 1.3k
Joseph C. Kidney United Kingdom 17 707 0.9× 470 0.6× 96 0.4× 47 0.4× 119 1.2× 32 1.1k
Gabriella Guarnieri Italy 17 446 0.5× 314 0.4× 80 0.4× 39 0.3× 53 0.5× 63 765
René Aalbers Netherlands 24 1.5k 1.8× 1.6k 2.0× 323 1.5× 100 0.8× 210 2.1× 64 2.0k
Piero Emilio Balbo Italy 18 790 1.0× 446 0.6× 23 0.1× 74 0.6× 215 2.2× 48 1.3k
Luis Manuel Entrenas Costa Spain 11 401 0.5× 403 0.5× 86 0.4× 42 0.3× 33 0.3× 33 995
G. Duru France 16 248 0.3× 386 0.5× 67 0.3× 120 0.9× 43 0.4× 43 1.3k
Umur Hatipoğlu United States 17 547 0.7× 318 0.4× 30 0.1× 85 0.7× 44 0.4× 69 1.1k
Jill P. Karpel United States 23 960 1.2× 692 0.9× 98 0.5× 77 0.6× 19 0.2× 52 1.3k
Juan Carlos Cardet United States 18 377 0.5× 587 0.7× 128 0.6× 87 0.7× 195 2.0× 43 897
Alison Chisholm United Kingdom 25 1.4k 1.7× 1.2k 1.6× 161 0.7× 93 0.7× 48 0.5× 57 1.8k

Countries citing papers authored by Claudio Micheletto

Since Specialization
Citations

This map shows the geographic impact of Claudio Micheletto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Micheletto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Micheletto more than expected).

Fields of papers citing papers by Claudio Micheletto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Micheletto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Micheletto. The network helps show where Claudio Micheletto may publish in the future.

Co-authorship network of co-authors of Claudio Micheletto

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Micheletto. A scholar is included among the top collaborators of Claudio Micheletto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Micheletto. Claudio Micheletto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schleich, Florence, Stelios Loukides, Rekha Chaudhuri, et al.. (2025). Mepolizumab Effectiveness in Severe Asthma With/Without Chronic Rhinosinusitis With Nasal Polyps: Real‐World Pooled Analysis. Allergy. 80(9). 2557–2571.
2.
Marco, Fabiano Di, Arschang Valipour, Claudio Jommi, et al.. (2025). Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action. International Journal of COPD. Volume 20. 1595–1612.
3.
Crisafulli, Ernesto, et al.. (2025). Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early‐Stage Lung Cancer. Thoracic Cancer. 16(2). e15515–e15515.
4.
Vaghi, Adriano, Maria Beatrice Bilò, Francesco Bini, et al.. (2024). The added value of targeting airway hyperresponsiveness by blocking thymic stromal lymphopoietin (TSLP) in the management of severe asthma. European Annals of Allergy and Clinical Immunology. 57(6). 243–243. 1 indexed citations
5.
Calabria, Silvia, Carlo Piccinni, Antonella Pedrini, et al.. (2023). EPH200 Healthcare Resource Consumption of Patients with Chronic Obstructive Pulmonary Disease Treated with Triple and Dual Therapy and Experiencing an Acute Exacerbation. Value in Health. 26(12). S239–S239. 1 indexed citations
6.
Sibani, Marcella, Lorenzo Maria Canziani, Elena Carrara, et al.. (2023). Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times. Antibiotics. 12(6). 1009–1009. 3 indexed citations
7.
Righi, Elda, Massimo Mirandola, Fulvia Mazzaferri, et al.. (2022). Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. Journal of Infection. 84(4). 566–572. 57 indexed citations
8.
Avancini, Alice, Lorenzo Belluomini, Ilaria Trestini, et al.. (2022). Integrating supportive care into the multidisciplinary management of lung cancer: we can’t wait any longer. Expert Review of Anticancer Therapy. 22(7). 725–735. 9 indexed citations
9.
Radovanovic, Dejan, Marco Contoli, Fulvio Braido, et al.. (2022). Future Perspectives of Revaluating Mild COPD. Respiration. 101(7). 688–696. 4 indexed citations
10.
Marco, Fabiano Di, Maria D’Amato, Francesco Lombardo, et al.. (2021). The Burden of Short-Acting β2-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program. Advances in Therapy. 38(7). 3816–3830. 15 indexed citations
11.
Pasello, Giulia, Jessica Menis, Sara Pilotto, et al.. (2020). How covid-19 pandemic impacted integrated care pathways for lung cancer: the experience of two Italian centers in veneto region. Tumori. 106. 73–74. 1 indexed citations
12.
Guerriero, Massimo, Zeno Bisoffi, Albino Poli, Claudio Micheletto, & Carlo Pomari. (2020). Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol. BMJ Open. 10(10). e040036–e040036. 3 indexed citations
13.
Caminati, Marco, Gianenrico Senna, Fulvia Chieco‐Bianchi, et al.. (2016). Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience. BMC Pulmonary Medicine. 16(1). 128–128. 32 indexed citations
14.
Micheletto, Claudio, et al.. (2014). Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study. SHILAP Revista de lepidopterología. 2 indexed citations
15.
16.
Negro, Roberto W. Dal, Paola Turco, Claudio Micheletto, et al.. (2007). Cost analysis of GER-induced asthma: A controlled study vs. atopic asthma of comparable severity. Respiratory Medicine. 101(8). 1814–1820. 6 indexed citations
17.
Micheletto, Claudio, et al.. (2006). The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.. PubMed. 38(5). 153–7. 2 indexed citations
18.
Micheletto, Claudio, et al.. (2005). EOSINOPHILIC INFLAMMATION AND BASEMENT MEMBRANE THICKNESS (BMT) IN ATOPIC AND IN GER-RELATED ASTHMA. CHEST Journal. 128(4). 147S–147S. 1 indexed citations
19.
20.
Negro, Roberto Walter Dal, Carlo Pomari, Silvia Tognella, & Claudio Micheletto. (2003). Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline. Pulmonary Pharmacology & Therapeutics. 16(4). 241–246. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph C. Kidney Breakdown of academic impact, for papers by Gabriella Guarnieri Breakdown of academic impact, for papers by René Aalbers Breakdown of academic impact, for papers by Piero Emilio Balbo Breakdown of academic impact, for papers by Luis Manuel Entrenas Costa Breakdown of academic impact, for papers by G. Duru Breakdown of academic impact, for papers by Umur Hatipoğlu Breakdown of academic impact, for papers by Jill P. Karpel Breakdown of academic impact, for papers by Juan Carlos Cardet Breakdown of academic impact, for papers by Alison Chisholm
Rankless by CCL
2026